跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Omnipaque - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Omnipaque
Approved
STANDARD
Omnipaque
GE Healthcare Ireland
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
26680cb62c496534
Company
GE Healthcare Ireland
Type
Standard
Approval Details
Approval Id
26680cb62c496534
Drug Approval Philippines Name
Omnipaque
Product Name
Omnipaque
Registration Number
DR-XY25810
Brand Name
Omnipaque
Generic Name
Iohexol
Dosage Form
Solution For Injection (Intravenous/Intra-arterial/Intrathecal/Body Caveties)
Dosage Strength
755 mg/ Ml (Equi. To 350mg/Ml Iodine)
Manufacturer
GE Healthcare Ireland
Importer
A. Menarini Philippines, Inc.
Company Detail Path
/organization/ge-healthcare-ireland-limited
Issuance Date
10 May 2024
Expiry Date
12 January 2030
Pharmacologic Category
Radiocontrast Medium
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
26680cb62c496534
Type
Standard
Back to Philippines FDA Approvals